CVE-2002-2446

Description

GE Healthcare Millennium MG, NC, and MyoSIGHT has a password of insite.genieacq for the insite account that cannot be changed without disabling product functionality for remote InSite support, which has unspecified impact and attack vectors.

Category

10.0
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 0.62%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://apps.gehealthcare.com/servlet/ClientServlet/2338955-100.pdf?REQ=RAA&DIRECTION=2338955-100&FILENAME=2338955-100.pdf&FILEREV=1&DOCREV_ORG=1
http://apps.gehealthcare.com/servlet/ClientServlet/2354459-100.pdf?REQ=RAA&DIRECTION=2354459-100&FILENAME=2354459-100.pdf&FILEREV=4&DOCREV_ORG=4
http://www.forbes.com/sites/thomasbrewster/2015/07/10/vulnerable-breasts/
https://twitter.com/digitalbond/status/619250429751222277
https://ics-cert.us-cert.gov/advisories/ICSMA-18-037-02

Frequently Asked Questions

What is the severity of CVE-2002-2446?
CVE-2002-2446 has been scored as a critical severity vulnerability.
How to fix CVE-2002-2446?
To fix CVE-2002-2446, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2002-2446 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2002-2446 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.